![]() |
Volumn 31, Issue 2, 2008, Pages 181-184
|
Bisphosphonates in the treatment of thalassemia-associated osteoporosis
|
Author keywords
Bisphosphonates; Osteoporosis; Thalassemia
|
Indexed keywords
ALENDRONIC ACID;
BISPHOSPHONIC ACID DERIVATIVE;
CALCIUM;
CLODRONIC ACID;
COLECALCIFEROL;
HEMOGLOBIN;
IRON CHELATING AGENT;
PAMIDRONIC ACID;
PLACEBO;
VITAMIN D;
ZOLEDRONIC ACID;
ABSENCE OF SIDE EFFECTS;
BLOOD TRANSFUSION;
BONE DENSITY;
BONE MASS;
BONE REMODELING;
BONE TURNOVER;
CLINICAL TRIAL;
DISEASE ASSOCIATION;
DRUG EFFICACY;
FRACTURE;
HUMAN;
MORBIDITY;
OSTEOLYSIS;
OSTEOPOROSIS;
REVIEW;
RISK REDUCTION;
THALASSEMIA MAJOR;
UNSPECIFIED SIDE EFFECT;
|
EID: 42649143229
PISSN: 03914097
EISSN: None
Source Type: Journal
DOI: 10.1007/BF03345587 Document Type: Review |
Times cited : (36)
|
References (27)
|